No shortage on file

SANDOZ FESOTERODINE FUMARATE

SANDOZ CANADA INCORPORATED

Quick answers

Is there a shortage of SANDOZ FESOTERODINE FUMARATE in Canada?

No. There is no current shortage of SANDOZ FESOTERODINE FUMARATE 8MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file3 products

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ACH-FESOTERODINE

ACCORD HEALTHCARE INC

8MG · DIN 02536005

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TOVIAZ

PFIZER CANADA ULC

4MG · DIN 02380021

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ FESOTERODINE FUMARATE

SANDOZ CANADA INCORPORATED

4MG · DIN 02521768

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

Sandoz Fesoterodine Fumarate 8 mg tablet

Sandoz Fesoterodine Fumarate 8 mg tablet; Out of specification (Diester impurity)

Type II2025-03-21

Moderate health risk

Possible match — not confirmed

SANDOZ FESOTERODINE FUMARATE

SANDOZ FESOTERODINE FUMARATE: The Diester impurity is out of specification in the affected lot(s)

Type II2024-12-09

Moderate health risk

Possible match — not confirmed

Sandoz Fesoterodine Fumarate 8 mg tablet

Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)

Type II2024-05-16

Moderate health risk

Possible match — not confirmed

DIN

02521776

Strength

8MG

Dosage Form

TABLET (EXTENDED-RELEASE)

Route

ORAL

Active Ingredient

FESOTERODINE FUMARATE

See all FESOTERODINE FUMARATE products →

Compare with another product →

Product Monograph

Product monograph is not available from Health Canada

View official Health Canada drug record ↗

Shortage History

2026-10-06

Resolved

Disruption of the manufacture of the drug.

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929